<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>13</Volume><Issue>9</Issue><PubDate PubStatus="epublish"><Year>2022</Year><Month>10</Month><Day>22</Day></PubDate></Journal><title locale="en_US">Does Recovered COVID‑19 Patients Have Protective Reactions in Subsequent Reexposures to the Virus?</title><FirstPage>2716</FirstPage><LastPage>2716</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz</affiliation></Author><Author><affiliation locale="en_US">Research Center of Psychiatry and Behavioral Sciences, Tabriz University of Medical Sciences, Tabriz</affiliation></Author><Author><affiliation locale="en_US">Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>22</Day></PubDate></History><abstract locale="en_US">Protective reactions or neutralized antibody produced after coronavirus disease 2019 (COVID‑19) infection has a major impact on herd immunity induction and outbreak control. This feature potentially can open up unique opportunities for disease management.[1]</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2716</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2716/717718557</pdf_url></Article></Articles>
